Arizona, AHCCCS and GLP-1s
No rule changed in Arizona this year. What happened instead is that the cost of changing one was worked out in public, twice, by the legislature's own budget staff. A November 2025 briefing reported what the plan covering state employees and retirees already spends on these drugs and what it would spend if the weight indication were added. A fiscal note did the same arithmetic for the Medicaid program. Then a study committee wrapped up in December with three recommendations, none of which requires anybody to pay for a prescription.
What changed, and what the document says
The state employee plan, on weight loss
Not coveredThe plan that covers active and retired state workers pays for several GLP-1s, and excludes the indication most shoppers are asking about.
“The plan does not cover any drug solely for the purpose of weight loss/obesity.”
Arizona Joint Legislative Budget Committee — November 25, 2025
What it spends anyway
ContextThe exclusion is about the indication, not the molecule — the same plan's diabetes spending on this drug class runs into eight figures.
“In Plan Year 2025, spending on GLP-1s was $28 M.”
Arizona Joint Legislative Budget Committee — November 25, 2025
Per person, per year
ContextBudget staff published the per-member figure rather than only the total, which is the number a cash shopper can actually compare against.
“Average annual amount paid per member was $8,637.”
Arizona Joint Legislative Budget Committee — November 25, 2025
Medicaid's rule, in the agency's own slide
Not coveredThe Medicaid agency told the committee directly where it stands, and the committee printed the slide in its final report.
“AHCCCS currently does not cover GLP-1 for the treatment of obesity.”
Arizona State Legislature, Obesity Treatment Study Committee — December 2025
The single carve-out the agency names
Conditions applyOne drug, one purpose, and a prior authorization — the heart-risk indication survives where the weight indication does not.
“AHCCCS also covers 1 GLP-1 Receptor Agonist (Wegovy) in specific circumstances to reduce the risk of major adverse cardiovascular events when medically necessary and approved via prior authorization.”
Arizona State Legislature, Obesity Treatment Study Committee — December 2025
What the change was priced at
ContextA fiscal note on a bill that would have required comprehensive obesity coverage put a range on it and then warned readers about the range.
“we estimate the full-year cost of providing coverage of anti-obesity medication could range from $962.9 million-$2.5 billion on a Total Funds basis”
Arizona Joint Legislative Budget Committee Staff — 2/20/24
What the committee asked for in the end
ContextThree recommendations came out of the hearings. The first one is a definition, not a benefit.
“Officially recognize obesity as a chronic disease.”
Arizona State Legislature, Obesity Treatment Study Committee — December 2025
Which of these companies serve Arizona?
Of the 257 companies we grade, 25 publish a list of the states they are licensed in. We checked 229 more and found no such list on any page we read; 3 we have not checked either way.
20 of those lists name Arizona: Red Mountain Weight Loss, Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, ZYP Medical, The Virtual NP, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- State Employee Health Insurance – Coverage of Obesity Treatments — Arizona Joint Legislative Budget Committee. Date printed on the title slide: November 25, 2025.
- Obesity Treatment Study Committee Final Report — Arizona State Legislature, Obesity Treatment Study Committee. Month printed on the report's cover, under the title: December 2025.
- Fiscal Note, HB 2517 — AHCCCS; obesity treatment; medication — Arizona Joint Legislative Budget Committee Staff. Stamp printed in the footer of the note's last page: 2/20/24.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. None of the 3 rows below carries both a medication price and a monthly fee we could capture, so no figure here is a sum. Each cell says what its number covers and what we could not confirm, and every number was read on the seller's own page.
HealthiCare, Claya and Red Mountain Weight Loss pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| AVerified | HealthiCare | $147.90a month, medication onlycompounded personalized semaglutide, three-month planMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.$443.70 billed every three months.The lowest of the 6 medication prices we captured here | Wegovy tablets itemized at $268.68 and $448.79 by strength, so the one drug the Medicaid agency will authorize for heart risk has a cash number beside it. | See its prices at HealthiCare (opens in a new tab)Pays us nothing |
| CCaveat | Claya | $179a month, medication onlycompounded semaglutideMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.The semaglutide page's own floor for injectables. Tablets are listed at $279 on the same page.The lowest of the 3 medication prices we captured here | Branded pens quoted in cash, $1,299 for semaglutide and $1,399 for tirzepatide, which is the list-price end of the market the budget staff costed at $8,637 a member a year. | See its prices at Claya (opens in a new tab)Pays us nothing |
| FFail | Red Mountain Weight Loss | $99a month, medication onlycompounded GLP-1Medication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.The lowest of the 2 medication prices we captured here | An Arizona clinic, and one of the few sellers whose own published list names this state — read our note on the two different headline prices printed on one of its pages before you book. | See its prices at Red Mountain Weight Loss (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.